Nutritional supplements and personalized health diagnostics
Strategic Profile
In October 2023, L Catterton, a global consumer-focused private equity firm, completed its acquisition of Thorne HealthTech for approximately $680 million, resulting in Thorne's delisting from the NASDAQ. As of December 2025, Thorne HealthTech's revenue was $410.5 million USD, with revenue growth of 17% over the last year. The company leverages vertical integration across consumer supplements, health diagnostics, and personalized wellness technologies to compete in the premium preventive health market.
Cyborg Score Rationale
Thorne demonstrates strong market positioning with $410.5M in revenue (as of December 2025), 17% YoY growth, and a loyal customer base spanning 4 million consumers, 45,000 health professionals, and over 100 professional sports teams. The L Catterton acquisition (October 2023) provided substantial capital and strategic backing. However, the company faces significant competition in the fragmented nutritional supplements and personalized health testing markets, and recent private equity ownership may limit growth visibility.
Top Insights
The company went IPO on 2021-09-23 but was subsequently acquired by L Catterton and delisted in October 2023
Thorne leverages artificial intelligence models to provide insights and personalized data, products, and services to help individuals take a proactive approach to health
Onegevity uses AI and machine learning with a multi-omics database, while Thorne products include health tests, education, and nutritional supplements
Thorne has maintained 19% average annual revenue growth over the past three years
Named Competitors
Ortho Molecular Products — Clinical-grade nutritional supplements and nutraceuticals
Metagenics — Clinical nutrition and personalized health solutions
Xymogen — Professional-grade dietary supplements and practitioner networks
Designs for Health — Practitioner-dispensed nutritional supplements and functional medicine
Everlywell — At-home health diagnostics and telemedicine integration
Gainful — Personalized fitness supplement recommendations and nutrition
Recent Developments
(October 2023) Acquired by L Catterton in $680 million all-cash transaction; delisted from NASDAQ
(December 2025) Revenue reached $410.5M USD with 17% YoY growth
(2025) Continued expansion of Onegevity multi-omics AI platform and personalized health testing capabilities
Open the full interactive Thorne HealthTech, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.